КИМ Сон Пэ (KR),КИМ Кван Сон (KR),КИМ Вон Пэ (KR),КВАК Вие Чон (KR),ПАН Сон Хё (KR)
申请号：
RU2014119666/15
公开号：
RU2014119666A
申请日:
2014.05.15
申请国别(地区):
RU
年份:
2015
代理人:
摘要：
1. A pharmaceutical composition which contains, as an active ingredient, S-allyl-L-cysteine or a pharmaceutically acceptable salt, solvate or hydrate thereof for the manufacture of a medicament for the treatment or prevention of gastrointestinal disturbances induced by gastric acid drugs, alcohol , aspirin, indomethacin, or a combination thereof. 2. The pharmaceutical composition of claim 1, wherein the gastrointestinal disease is chronic gastritis, acute gastritis, gastric ulcer, gastric cancer, gastrointestinal bleeding, gastroesophageal reflux, duodenitis or duodenal ulcer. 3. The pharmaceutical composition of claim 1, wherein the acid of the gastric juice contains hydrochloric acid. The pharmaceutical composition of claim 1, wherein the alcohol is ethanol. The pharmaceutical composition of claim 1, wherein S-allyl-L-cysteine is isolated and purified from a plant belonging to the genus Allium, synthesized or obtained by fermentation. A pharmaceutical composition comprising a composition according to any one of claims. 1 or 2, which is selected from the group consisting of a composition for oral administration, a composition for administration through the mucosa, an injectable composition, a composition for inhalation and a composition for external use. 7. The pharmaceutical composition of claim 6 for oral administration, which is selected from the group consisting of hard and soft capsules, tablets, suspensions, powder, sustained-release formulations, enteral formulations, granules, oleosugars, microgranules, pills, extracts, liquids, aromatic waters , emulsions, syrups, elixirs, liquid extracts, tinctures, decoctions, us�1. Фармацевтическая композиция, которая содержит в качестве активного ингредиента S-аллил-L-цистеин или его фармацевтически приемлемую соль, сольват или гидрат для производства медикамента для лечения или предотвращения желудочно-кишечных нарушений, индуцированных лекарственными препаратами, представляющими собой кислоту желудочного сока, спирт,
